One of the most aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The most negative part about the disease is that more often than not it is detected in it’s late stages at which time it is more difficult to do anything about it.
As the effects of neuroendocrine colon cancer become visible only at very advanced stages, the rate of survival of the patient drops drastically The tumors are malignant and are usually detected with distant metastases. In several surveys, reports tell us that in a great many cases of neuroendocrine cancer ends in death.
Though chances of neuroendocrine carcinoma in colon are rare at best if one is affected the patient’s heath appears even worse than patients who suffer from adenocarcinoma.
Researches have showcased that the results of this cancer stay the same with age, sex or tumor location. However, neuroendocrine colon carcinoma does depend on the stage of the tumor. Normal trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. Though in several cases, if the tumor is in stage 3 or 4, it is a laborious and and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has few techniques to deal with this particular cancer. A more common technique that doctors regularly use is immunohistochemical staining methods. This method helps doctors with coping with the severity of the neuroendocrine colon cancer and really helps determine the best medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of said tumor with an antibody called A-80 which helps in identifying the quantum of neuroendocrine differentiation and the extent of damage on the health of the patient.
Neuroendocrine colon carcinoma is difficult to treat and in a certain study where several patients suffered from this particular disease were extensively examined an observation was made that the overall survival rate surrounding this disease was approximately seven months. While in a predominant stage, the rates were as less as five months. The great majority of these cases were at first found to be as carcinoids but later they developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery may not be a guaranteed treatment so, even surgery does not provide the patient with a proper cure. so it is critical to detect this disease quickly and provide proper medication for it.